Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
DRFT15
|
|||
| Drug Name |
CLBS12
|
|||
| Synonyms |
HONEDRA
Click to Show/Hide
|
|||
| Drug Type |
Cell therapy
|
|||
| Indication | Critical limb ischemia [ICD-11: BD4Y; ICD-9: 459.89] | Phase 2 | [1] | |
| Company |
Caladrius Biosciences
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT02501018) Study to Assess the Efficacy and Safety of CLBS12 in Patients With Critical Limb Ischemia (CLI). U.S. National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.